Who are Intravenous Glucocorticoids's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Medrol, Prelone, Oral prednisolone Taper, Methyl Prednisolonate, prednison, Azenil, standard prednisolone treatment.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intravenous-glucocorticoids.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Intravenous Glucocorticoids — Competitive Intelligence Brief

Intravenous Glucocorticoids (Intravenous Glucocorticoids) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glucocorticoid. Area: Oncology.

phase 2 Glucocorticoid Glucocorticoid receptor (GR) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Intravenous Glucocorticoids (Intravenous Glucocorticoids) — Guangzhou JOYO Pharma Co., Ltd. Glucocorticoids exert their effects by binding to the glucocorticoid receptor (GR) in the cytoplasm.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Intravenous Glucocorticoids TARGET	Intravenous Glucocorticoids	Guangzhou JOYO Pharma Co., Ltd	phase 2	Glucocorticoid	Glucocorticoid receptor (GR)
Medrol	methylprednisolone	Generic (originally Upjohn/Pfizer)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor	1957-10-01
Prelone	prednisolone	Generic (originally Schering)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1	1955-01-01
Oral prednisolone Taper	Oral prednisolone Taper	Berinstein, Jeffrey	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Methyl Prednisolonate	Methyl Prednisolonate	Ain Shams University	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
prednison, Azenil	prednison, Azenil	Tel-Aviv Sourasky Medical Center	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
standard prednisolone treatment	standard prednisolone treatment	Institute of Child Health	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glucocorticoid class)

Research in Real-Life Ltd · 2 drugs in this class
NICHD Neonatal Research Network · 2 drugs in this class
UMC Utrecht · 2 drugs in this class
University of Pennsylvania · 2 drugs in this class
First Affiliated Hospital of Zhejiang University · 1 drug in this class
GlaxoSmithKline · 1 drug in this class
ClinAmygate · 1 drug in this class
Instituto de Investigación Sanitaria y Biomédica de Alicante · 1 drug in this class
First Affiliated Hospital of Wenzhou Medical University · 1 drug in this class
Guangzhou JOYO Pharma Co., Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intravenous Glucocorticoids — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-glucocorticoids. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab